Mounjaro and Boils: Skin Changes Worth Understanding

What tirzepatide's trial data actually recorded about skin

The SURMOUNT-1 trial (the phase 3 study that underpins Mounjaro's weight-management licence) followed 2,539 adults over 72 weeks and systematically recorded adverse events across every body system. Injection-site reactions were the skin-related finding that showed up with any consistency: localised redness, mild swelling, and itching at the point of the weekly injection. These were generally mild and transient. Boils, abscesses, or folliculitis were not identified as effects attributable to tirzepatide, the active ingredient in Mounjaro, in that programme. The same pattern holds in the SURPASS diabetes trials that form the broader clinical dataset. That is not a guarantee that an individual patient will never develop a boil while taking Mounjaro (correlation and causation are different things, and coincidental events happen) but it does mean there is no signal, as of the current evidence base, pointing to tirzepatide as a trigger, and our guidance on eating boiled eggs on Mounjaro is a good example of the kind of practical detail we cover for people thinking carefully about their diet on treatment. The NHS medicines page for tirzepatide lists the recognised side effects and does not include boils among them.

A question our prescribers hear most weeks runs something like: "I've developed something on my skin since starting, is it the pen?" The honest answer is: possibly, but probably not in the way the patient fears. New symptoms during any treatment period prompt the same clinical instinct, rule out what the medicine is known to do, consider timing, consider other factors.

Why people on Mounjaro sometimes notice skin changes unrelated to the medicine itself

Tirzepatide works partly by slowing gastric emptying and significantly reducing caloric intake over months. Rapid or substantial weight loss (the kind that SURMOUNT-1 documented at around 20% of body weight on the highest dose) can coincide with shifts in hormone levels, sebaceous gland activity, and skin texture. These changes are not caused by tirzepatide's pharmacology in any direct sense; they are downstream effects of losing weight quickly. Skin can become drier. Hormonal fluctuations during significant weight change occasionally affect sebum production, which in turn can create conditions where blocked follicles or minor infections are slightly more likely. None of this is Mounjaro doing something to your skin, it is your body adapting to a substantial change in fat mass and metabolic state. The distinction matters, because the management is different: moisturising, staying well hydrated, and good skin hygiene address these changes far better than adjusting or stopping your treatment would. Those same hormonal shifts are why patients sometimes ask about how Mounjaro interacts with the coil, since contraception and cycle changes are part of the broader picture for many people on treatment. If you are curious about how significant the metabolic shift can be, our overview of what Mounjaro is and how it works covers the mechanism in more detail.

Injection-site care and when a skin symptom needs prompt attention

The one skin issue that is directly linked to Mounjaro is localised injection-site reaction. Rotating sites (abdomen, thigh, upper arm) reduces the chance of repeated tissue irritation at the same spot. Cleaning the area with an alcohol swab before injection and allowing it to dry fully both reduce the small bacterial load on the skin surface. A lump, redness, or warm patch at an injection site that persists beyond a couple of days, or that grows, becomes painful, or starts producing discharge, should be assessed by a clinician, not because tirzepatide is likely to blame, but because any infection at a puncture site can occasionally track deeper if left. The MHRA's Yellow Card scheme exists precisely so that unexpected skin reactions (or anything else that feels attributable to a medicine) can be reported and analysed at population level, contributing to the ongoing safety picture for newer medicines like Mounjaro, which carries the Black Triangle (▼) designation indicating it is under additional post-marketing surveillance. If you are managing a long-term condition alongside your weight treatment, our page on Mounjaro and MS illustrates how the prescribing team thinks about co-existing conditions, and for male patients our page on Mounjaro and erectile dysfunction addresses another area where people often want more clinical detail. More broadly, anything that feels urgent or that is spreading quickly (a painful red area, fever, feeling unwell) warrants same-day medical attention, not a message to a pharmacy. That applies whether or not you are on any weight-loss medicine. For questions about how Mounjaro interacts with other aspects of health, the nume FAQs cover many of the common ones, and our support team is available seven days a week. If you are considering starting treatment and want to understand the full clinical picture, check your eligibility with our prescribers, the consultation is free, thorough, and reviewed the same day by a GPhC-registered prescriber.